No profile data available.
BioRestorative Therapies, Inc. (BRTX) is an essential consumer products company in the dermatological treatment items industry, based in Melville, United States, with about 13 full-time employees.
It reported revenue of $401,000 for fiscal year 2024, and net income of -$8.98 million. In Q3 2025 (the quarter ended September 30, 2025) revenue was $11,800, down 94.9% from a year before. Its market capitalization was $2.64 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. The company develops programs related to the treatment of disc/spine disease and metabolic disorders.
BioRestorative Therapies reported $401,000 in revenue for fiscal year 2024. In Q3 2025 revenue was $11,800.
$2.64 million as of October 9, 2026.
Listed companies of a similar size in the same industry (dermatological treatment items) include Solesence, Inc. (SLSN), Pacific Software, Inc. (PFSF), CCA Industries, Inc. (CAWW), Sentient Brands Holdings Inc. (SNBH).